AstraZeneca: CHMP Recommends Enhertu For Approval In The EU
(RTTNews) - AstraZeneca (AZN, AZN.L, ZEG.DE, AZN.ST) and Daiichi Sankyo's (4568.T) Enhertu has been recommended for approval in the European Union by CHMP as a monotherapy for the adjuvant treatment of adult patients with resected HER2-positive breast cancer who have residual inv
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.